Cystic fibrosis transmembrane conductance regulator mutations in azoospermic and oligospermie men and their partners

Reproductive BioMedicine Online

Volumn 19, Issue 5, 2009, Pages 685-694

  Gallati, Sabina ^a   Hess, Simone ^a   Galié Wunder, Dorothea ^a   Berger Menz, Elisabeth ^b   Böhlen, Dominik ^c  

^a UNIVERSITY OF BERN   (Switzerland)

^b Lindenhofspital   (Switzerland)

^c St Claraspital Basel   (Switzerland)

Author keywords

Assisted reproduction; Cystic fibrosis transmembrane conductance regulator; Mutation spectrum; Polyvariant mutants; Primary infertility; Risk for offspring

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; ARTICLE; AZOOSPERMIA; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; OLIGOSPERMIA; RISK FACTOR;

EID: 74949085091     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rbmo.2009.09.002     Document Type: Article

References (45)

1. Anguiano A, Oates RD, Amos JA et al. 1992 Congenital bilateral absence of the vas deferens. A primarily genital form of cystic fibrosis. Journal of the American Medical Association 267, 1794-1797.
2. Blau H, Freud E, Mussaffi H et al. 2002 Urogenital abnormalities in male children with cystic fibrosis. Archives of Disease in Childhood 87, 135-138.
3. Boucher D, Creveaux I, Grizard G et al. 1999 Screening for cystic fibrosis transmembrane conductance regulator gene mutations in men included in an intracytoplasmic sperm injection programme. Molecular Human Reproduction 5, 587-593.
4. Buratti E, Dork T, Zuccato E et al. 2001 Nuclear factor TDP-43 and SR proteins promote in-vitro and in-vivo CFTR exon 9 skipping. European Molecular Biology Organization Journal 20, 1774-1784.
5. Burrello N, Calogero AE, De Palma A et al. 2002 Chromosome analysis of epididymal and testicular spermatozoa in patients with azoospermia. European Journal of Human Genetics 10, 362-366.
6. Casals T, Bassas L, Egozcue S et al. 2000 Heterogeneity for mutations in the CFTR gene and clinical correlations in patients with congenital absence of the vas deferens. Human Reproduction 15, 1476-1483.
7. Chillon M, Casals T, Mercier B et al. 1995 Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. New England Journal of Medicine 332, 1475-1480.
8. Claustres M 2005 Molecular pathology of the CFTR locus in male infertility. Reproductive BioMedicine Online 10, 14-41.
9. Claustres M, Guittard C, Bozon D et al. 2000 Spectrum of CFTR mutations in cystic fibrosis and in congenital absence of the vas deferens in France. Human Mutation 16, 143-156.
10. Cuppens H, Cassiman JJ 2004 CFTR mutations and polymorphisms in male infertility. International Journal of Andrology 27, 251-256.
11. Cuppens H, Lin W, Jaspers M et al. 1998 Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. Journal of Clinical Investigation 101, 487-496.
12. de Meeus A, Guittard C, Desgeorges M et al. 1998 Linkage disequilibrium between the M470V variant and the 1VS8 polyT alleles of the CFTR gene in CBAVD. Journal of Medical Genetics 35, 594-596.
13. Disset A, Michot C, Harris A et al. 2005 A T3 allele in the CFTR gene exacerbates exon 9 skipping in vas deferens and epididymal cell lines and is associated with congenital bilateral absence of vas deferens (CBAVD). Human Mutation 25, 72-81.
14. Dohle GR, Halley DJ, Van Hemel JO et al. 2002 Genetic risk factors in infertile men with severe oligozoospermia and azoospermia. Human Reproduction 17, 13-16.
15. Douet-Guilbert N, Bris MJ, Amice V et al. 2005 Interchromosomal effect in sperm of males with translocations: report of 6 cases and review of the literature. International Journal of Andrology 28, 372-379.
16. Faddy MJ, Silber SJ, Gosden RG 2001 Intra-cytoplasmic sperm injection and infertility. Nature Genetics 29, 131.
17. Foresta C, Ferlin A, Gianaroli L et al. 2002 Guidelines for the appropriate use of genetic tests in infertile couples. European Journal of Human Genetics 10, 303-312.
18. Grangeia A, Sa R, Carvalho F et al. 2007 Molecular characterization of the cystic fibrosis transmembrane conductance regulator gene in congenital absence of the vas deferens. Genetics in Medicine 9, 163-172.
19. Groman JD, Hefferon TW, Casals T et al. 2004 Variation in a repeat sequence determines whether a common variant of the cystic fibrosis transmembrane conductance regulator gene is pathogenic or benign. American Journal of Human Genetics 74, 176-179.
20. Healy DL, Trounson AO, Andersen AN 1994 Female infertility: causes and treatment. Lancet 343, 1539-1544.
21. Hefferon TW, Broackes-Carter FC, Harris A et al. 2002 Atypical 5′ splice sites cause CFTR exon 9 to be vulnerable to skipping. American Journal of Human Genetics 71, 294-303.
22. Hellani A, Ai-Hassan S, Iqbal M et al. 2006 Y chromosome microdeletions in infertile men with idiopathic oligo- or azoospermia. Journal of Experimental and Clinical Assisted Reproduction 3, 1.
23. Jarvi K, Zielenski J, Wilschanski M et al. 1995 Cystic fibrosis transmembrane conductance regulator and obstructive azoospermia. Lancet 345, 1578.
24. Keymolen K, Goossens V, De Rycke M et al. 2007 Clinical outcome of preimplantation genetic diagnosis for cystic fibrosis: the Brussels' experience. European Journal of Human Genetics 15, 752-758.
25. Kihaile PE, Yasui A, Shuto Y 2005 Prospective assessment of Y-chromosome microdeletions and reproductive outcomes among infertile couples of Japanese and African origin. Journal of Experimental and Clinical Assisted Reproduction 2, 9.
26. Larriba S, Bonache S, Sarquella J et al. 2005 Molecular evaluation of CFTR sequence variants in male infertility of testicular origin. International Journal of Andrology 28, 284-290.
27. Liechti-Gallati S, Schneider V, Neeser D et al. 1999 Two buffer PAGE system-based SSCP/HD analysis: a general protocol for rapid and sensitive mutation screening in cystic fibrosis and any other human genetic disease. European Journal of Human Genetics 7, 590-598.
28. Maeda Y, Shiratsuchi A, Namiki M et al. 2002 Inhibition of sperm production in mice by annexin V microinjected into seminiferous tubules: possible etiology of phagocytic clearance of apoptotic spermatogenic cells and male infertility. Cell Death and Differentiation 9, 742-749.
29. Mak V, Zielenski J, Tsui LC et al. 2000 Cystic fibrosis gene mutations and infertile men with primary testicular failure. Human Reproduction 15, 436-439.
30. Mak V, Zielenski J, Tsui LC et al. 1999 Proportion of cystic fibrosis gene mutations not detected by routine testing in men with obstructive azoospermia. Journal of the American Medical Association 281, 2217-2224.
31. Mau-Holzmann UA 2005 Somatic chromosomal abnormalities in infertile men and women. Cytogenetic and Genome Research 111, 317-336.
32. Mennicke K, Klingenberg RD, Bals-Pratsch M et al. 2005 Rational approach to genetic testing of cystic fibrosis (CF) in infertile men. Andrologia 37, 1-9.
33. Mickle J, Milunsky A, Amos JA et al. 1995 Congenital unilateral absence of the vas deferens: a heterogeneous disorder with two distinct subpopulations based upon aetiology and mutational status of the cystic fibrosis gene. Human Reproduction 10, 1728-1735.
34. Pagani F, Buratti E, Stuani C et al. 2000 Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element. Journal of Biological Chemistry 275, 21041-21047.
35. Pallares-Ruiz N, Carles S, Des Georges M et al. 1999 Complete mutational screening of the cystic fibrosis transmembrane conductance regulator gene: cystic fibrosis mutations are not involved in healthy men with reduced sperm quality. Human Reproduction 14, 3035-3040.
36. Patrizio P, Salameh WA 1998 Expression of the cystic fibrosis transmembrane conductance regulator (CFTR) mRNA in normal and pathological adult human epididymis. Journal of Reproduction and Fertility Supplement 53, 261-270.
37. Ratbi I, Legendre M, Niel F et al. 2007 Detection of cystic fibrosis transmembrane conductance regulator (CFTR) gene rearrangements enriches the mutation spectrum in congenital bilateral absence of the vas deferens and impacts on genetic counselling. Human Reproduction 22, 1285-1291.
38. Ravnik-Glavac M, Svetina N, Zorn B et al. 2001 Involvement of CFTR gene alterations in obstructive and nonobstructive infertility in men. Genetic Testing 5, 243-247.
39. Riordan JR, Rommens JM, Kerem B et al. 1989 Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245, 1066-1073.
40. Stuppia L, Antonucci I, Binni F et al. 2005 Screening of mutations in the CFTR gene in 1195 couples entering assisted reproduction technique programs. European Journal of Human Genetics 13, 959-964.
41. Tamburino L, Guglielmino A, Venti E et al. 2008 Molecular analysis of mutations and polymorphisms in the CFTR gene in male infertility. Reproductive BioMedicine Online 17, 27-35.
42. Trezise AE, Linder CC, Grieger D et al. 1993 CFTR expression is regulated during both the cycle of the seminiferous epithelium and the oestrous cycle of rodents. Nature Genetics 3, 157-164.
43. van der Ven K, Messer L, van der Ven H et al. 1996 Cystic fibrosis mutation screening in healthy men with reduced sperm quality. Human Reproduction 11, 513-517.
44. Wang X, Sharma RK, Sikka SC et al. 2003 Oxidative stress is associated with increased apoptosis leading to spermatozoa DNA damage in patients with male factor infertility. Fertility and Sterility 80, 531-535.
45. Xu WM, Shi QX, Chen WY et al. 2007 Cystic fibrosis transmembrane conductance regulator is vital to sperm fertilizing capacity and male fertility. Proceedings of the National Academy of Sciences of the United States of America 104, 9816-9821.